An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
Osteoarthritis, Knee
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Osteoarthritis
Eligibility Criteria
Inclusion Criteria: Osteoarthritis of both knees for minimum of six months Moderate pain in the most involved knee when not taking NSAIDs Must have used an oral NSAID on at least three days per week for last three months or 25 of 30 days before screening Demonstrate x-ray evidence of osteoarthritis in the most involved knee during the last six months Exclusion Criteria: Grade 1 or Grade 4 severity of the most involved knee based on x-ray criteria Intra-articular injections or arthroscopy of the most involved knee during three months before Screening visit Inflammation of the most involved knee that could be related to gout or pseudogout-induced synovitis or infection A large bulging effusion History of gout or pseudo-gout induced synovitis or infection of the more severe knee History of partial or total knee replacement in either knee
Sites / Locations
- Drug Research and Analysis Corporation
- Cumberland Research Associates L L C
- Community Research Managment Associates